Erie Indemnity (ERIE) has drawn fresh attention after its recent share price slide, with the stock down over the past week, month and year, even as its 5 year return remains positive.
The shorter term picture for Erie Indemnity looks weak, with the share price down 6.96% over the past week and 6.33% over the last month. By contrast, a 6.06% 90 day gain and a 46.77% five year total shareholder return point to much stronger long run results.
Spot fresh ideas by comparing Erie Indemnity's recent pullback with our hand picked 18 high quality undiscovered gems, which also pair solid fundamentals with under-the-radar share price moves.For Erie Indemnity, a pullback after a strong multi year run tempts some investors to step in now, while others prefer to wait on the sidelines. Does the current valuation already reflect that tension, or does it leave a margin of safety?
Preferred P/E of 21.8x: Is it justified?
Erie Indemnity now trades at a P/E of 21.8x, while the SWS DCF model suggests fair value of $262.74 against a last close of $240.40.
The P/E ratio compares what investors pay for each dollar of current earnings. For an insurance related business like Erie Indemnity, that multiple often reflects how durable investors think fee income and profitability will be over time.
On one hand, the SWS DCF model points to the shares trading at roughly an 8.5% discount to an estimate of future cash flow value. This leans toward a more supportive view of the current price. On the other hand, earnings fell 7.7% over the past year, current net profit margins of 14% are below last year's 15.7%, and the stock has lagged both the US market and the broader insurance sector over 12 months. Together, these factors can make a premium earnings multiple harder to defend.
The comparison with peers is clear. Management's P/E of 21.8x is described as expensive against a specific peer group at 12.8x and also compared with the wider US insurance industry on 11.2x. That is a hefty gap which implies investors are paying a materially higher price for each dollar of Erie Indemnity earnings than for many competitors.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-earnings of 21.8x (OVERVALUED)
Still, the recent 1 year share price decline and softer earnings and margin picture leave Erie Indemnity exposed if profitability or fee income come under further pressure.
Find out about the key risks to this Erie Indemnity narrative.
Another view on Erie Indemnity's value
The SWS DCF model paints a different picture to the rich 21.8x P/E. On that cash flow lens, Erie Indemnity at $240.40 screens about 8.5% below an estimated fair value of $262.74.
That split verdict between earnings multiple and cash flow estimate leaves you with a simple question. Which signal should carry more weight when you think about risk and return over the next few years.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Erie Indemnity for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 33 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
There have been mixed messages so far about Erie Indemnity's value. If you want to move quickly and form your own view, spend a few minutes with the 2 key rewards.
Looking for more investment ideas beyond Erie Indemnity?
Erie Indemnity gives useful context, but your next move likely comes from comparing it with other high quality candidates that fit your own risk and return preferences.
- Target dependable compounding by scanning a curated 6 dividend fortresses that focuses on businesses prioritizing consistent income potential and financial resilience.
- Hunt for potential mispricings using the 33 high quality undervalued stocks to quickly spot companies where fundamentals and market pricing appear out of step.
- Broaden your opportunity set with the 21 elite penny stocks with strong financials and see which smaller companies combine higher risk with focused financial strength.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com